The contents of this website are intended for US Healthcare Professionals only.

x

Indication

ZILBRYSQ® (zilucoplan) is indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive.

For US Healthcare Professionals Only Full Prescribing Information | Important Safety Information
UCBZilbrysq

Click here to reset your password

Don't have an account?

Create a New Account


Logo
Important Safety Information Privacy Policy Terms Of Use Unsubscribe

UCB respects your privacy. Click here to manage your email preferences.
This site is intended for U.S. healthcare professionals.
ZILBRYSQ® and ONWARD® are registered trademarks of the UCB Group of Companies. All other trademarks and registered trademarks are the property of their respective holders.
©2025 UCB, Inc., Smyrna, GA 30080.
All rights reserved.
US-ZL-2400344